VDAC1 excess has been observed in pathologies of the nervous system associated with cell loss [22–24], such as in the brains of post-mortem AD patients, AD-like transgenic mice [25, 26], and other neurodegenerative disease models [27]. Here, VDAC1 is linked to Alzheimer disease.